Merck KGaA, Darmstadt, Germany, Response on European Commission Statement of Objections July 6, 2017July 12, 2017 by / Share This.....LinkedinTwitterFacebookGoogleEmailDownload PDF Related News: Ronapreve approved by European Commission to treat…European Commission approves Roche’s Gavreto…Actemra/RoActemra approved by the European…Roche’s Polivy combination approved by European…European Commission approves Roche’s Tecentriq as…European Commission approves Roche’s first-in-class…
